Development of a multiplexed PCR-coupled liquid bead array assay for vascular endothelial growth factor (VEGF) splice variants

详细信息	查看全文 | 推荐本文 |

• 作者：C. Parisi ; A. Markou ; E.S. Lianidou ; ^{lianidou@chem.uoa.gr}
• 关键词：Angiogenesis ; VEGF ; VEGF splice variants ; Liquid bead array ; Multiplex PCR ; Non-small cell lung cancer ; Personalized medicine
• 刊名：Clinical Biochemistry
• 出版年：2012
• 期刊代码：55_00099120
• 类别：med
• 出版时间：April, 2012
• 卷：45
• 期：6
• 页码：475-482
• 文件大小：943 K

摘要

Objectives

To develop a multiplex PCR-coupled liquid bead array assay for the expression of VEGF splice variants.

Design and methods

The assay was based on the combination of multiplex PCR with liquid bead array technology, and optimized and evaluated in terms of analytical sensitivity, specificity, and reproducibility using the MCF-7 cell line. Clinical performance was evaluated in 16 pairs of fresh frozen cancerous and corresponding noncancerous adjacent tissues from NSCLC patients.

Results

The assay is highly sensitive, reproducible and can detect specifically VEGF splice variants in clinical samples. When applied in 32 clinical samples it gave comparable results to RT-qPCR (concordance of 81%, 75%, 88%and 81%for PBGD, VEGF₁₂₁, VEGF₁₆₅, and VEGF₁₈₉ respectively).

Conclusions

The developed assay can simultaneously detect three VEGF splice variants with high specificity and sensitivity and can be further used to evaluate the role of each individual VEGF splice variant in molecular therapies targeted against VEGF.